Transplant
15 Aug 2025
10:30
12:00
TICC - 2F 201DE
Kidney Transplant
| Time | Session |
|---|---|
|
10:30
12:00
|
Cheng-Kuang YangTaiwan
Moderator
Robotic Radical Prostatectomy: Trying to Fit the Right Surgery to the Right PatientDefinitive treatment for localized prostate cancer included radical prostatectomy and radiation. Successful criteria of radical prostatectomy have to meet oncology control, not persistent PSA after surgery without salvage therapy. MRI imaging stage and PSA density are predictors for short‐term BCR after prostatectomy. NCCN‐defined high‐risk patients with a high initial PSA 28 density, imaging stage (T3aN0M0 and T3bN0M0), and 29 pathologic stage (any N1) had a higher risk of BCR when 30 compared with other patients with undetectable PSA, while 31 those with pathologic stage (T3bN0M0 or any N1) displayed 32 a higher risk of postoperatively detectable PSA. These find‐ 33 ings may help urologists to identify patients for whom active 34 therapeutic protocols are necessary.
|
|
10:30
10:50
|
Alvin WeeUnited States
Speaker
How to Build Up a Strong Kidney Transplant Program with Continuing Growth?Transplantation is one of the most complex, highly regulated, multidisciplinary fields in medicine, requiring the coordination and dedication of a highly skilled and collaborative team.
At this conference, we’re honored to share our journey—highlighting the challenges, milestones, and strategic innovations that have shaped our transplant program. Through intentional planning, data-driven practices, and a strong team culture, we’ve grown to become the leading transplant center in the nation, recognized for both volume and quality outcomes.
Our hope is that by sharing our experience, we can contribute valuable insights to the transplant community and support others in advancing excellence in patient care.
Robotic Kidney Transplantation: The Way to Go?!The utilization of robotics in urologic surgery continues to grow, offering enhanced precision, improved outcomes, and faster recovery times. In the field of kidney transplantation, robotic-assisted techniques are now gaining significant momentum. The Cleveland Clinic Main Campus has emerged as the largest single center performing robotic-assisted kidney transplants annually—not only in the United States but also worldwide.
With this unparalleled experience, we are well positioned to share key advantages we have observed over traditional open surgical methods. As robotic technology continues to evolve, our experience reinforces its growing role in transforming the field of kidney transplantation and improving patient outcomes.
|
|
10:50
11:10
|
Ho-Yee TiongSingapore
Speaker
Living kidney donation with AI - Augmented or ArtificialAt the National University Hospital, we have utilized AI to try improving our pre-operative and peri-operative management of our patients for donor nephrectomy. This presentation shares the benefit of the learning experience of using AI through a standardized procedure like donor nephrectomy.
|
|
11:10
11:30
|
Brian K. LeeUnited States
Speaker
Genetic Testing in the Evaluation of Recipient Candidates and Living Kidney DonorWith the advent of more affordable next generation sequencing with ever faster turnaround times, precision medicine has taken on a more prominent role in clinical practice. This has meant that when determining the most appropriate course of action when evaluating potential kidney transplant recipients, genetic ascertainment of the underlying cause of their ESKD/CKD has become an increasingly indispensable tool. At the same time, related living kidney donors, especially those who are young, and who may not have any manifestations of renal symptoms can now be genetically tested to reassure transplant professionals and donors and their families that they are unlikely to harbor a hereditary condition that could jeopardize their future renal function. And yet the interpretation of genetic testing results is not part of the regular nephrology/transplant curriculum, and many centers do not have readily accessible medical geneticists or genetic counselors at their disposal, making the appropriate triaging of recipient and donor candidates alike somewhat of a black box. Through this session, we hope to elucidate the tough decisions and triumphs that comes with recognizing both the powers and the limitations of using genetic tests in transplant recipient and donor evaluations. Non-Invasive Immune MonitoringThe success of kidney transplantation is dependent on the close monitoring of kidney function and the net immune status of the host recipient. Traditional biomarkers such as serum creatinine are unreliable at best, often lagging behind histologic evidence of anti-graft activity when protocol biopsies are performed which could jeopardize opportunities for clinicians to intervene timely. Surveillance renal allograft biopsies have been employed in an attempt to match clinical outcomes with histologic findings, but this invasive procedure could lead to bleeding complications and is time- and labor intensive. Better immune monitoring has recently become more widely adopted in transplant practice, and its introduction could allow closer follow-up of the recipient and shed light on the state of immune milieu.
|
|
11:30
11:50
|
|
|
11:50
12:00
|